Vioxx
Term · Oncology and biomedicine · MLC-T-ONC-009246
A drug that was being used for pain relief and was being studied for its ability to prevent cancer and to prevent the growth of new blood vessels that tumors need to grow. It is a type of nonsteroidal anti-inflammatory drug and a type of antiangiogenesis agent. Vioxx was taken off the market in the U.S. because of safety concerns. Also called rofecoxib.
| Identifier | MLC-T-ONC-009246 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | rofecoxib |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009246",
"term": "Vioxx",
"field": "Oncology and biomedicine",
"definition": "A drug that was being used for pain relief and was being studied for its ability to prevent cancer and to prevent the growth of new blood vessels that tumors need to grow. It is a type of nonsteroidal anti-inflammatory drug and a type of antiangiogenesis agent. Vioxx was taken off the market in the U.S. because of safety concerns. Also called rofecoxib.",
"synonyms": [
"rofecoxib"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/vioxx/"
}
Record 17,244 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.